[
  {
    "ts": null,
    "headline": "Jim Cramer on Johnson & Johnson (JNJ): How the Pharma Giant is Handling Billion-Dollar Lawsuits and Legal Battles",
    "summary": "We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discussed recently. As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street […]",
    "url": "https://finnhub.io/api/news?id=4134ae3da7f62eaf3602d4dbac5621cfca40d35196db4e336ab3c9d9e9afc3f7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734551780,
      "headline": "Jim Cramer on Johnson & Johnson (JNJ): How the Pharma Giant is Handling Billion-Dollar Lawsuits and Legal Battles",
      "id": 132045249,
      "image": "https://s.yimg.com/ny/api/res/1.2/DBFyZ0OZ_JyFkP8R8eQoiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discussed recently. As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street […]",
      "url": "https://finnhub.io/api/news?id=4134ae3da7f62eaf3602d4dbac5621cfca40d35196db4e336ab3c9d9e9afc3f7"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
    "summary": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=802a1a30a94d3dd76cfdee2ae9c1702715552c546297421639a9f6ead4d0a1b8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734539460,
      "headline": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
      "id": 132064820,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=802a1a30a94d3dd76cfdee2ae9c1702715552c546297421639a9f6ead4d0a1b8"
    }
  },
  {
    "ts": null,
    "headline": "Of 63 Fortune500 Industry Leaders, 57 Pay Dividends, 38 Test 'Safer' & 1 Is Ideal To Buy",
    "summary": "Top 10 Fortune 500 industry leaders show strong yields. See why Energy Transferâs high-dividend, low-price stock stands out as a safer buy in December.",
    "url": "https://finnhub.io/api/news?id=294dcff3250f20a4f41dbf0edac6759822db14a529fa357fbddcf1120756d296",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734531309,
      "headline": "Of 63 Fortune500 Industry Leaders, 57 Pay Dividends, 38 Test 'Safer' & 1 Is Ideal To Buy",
      "id": 132040863,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155071595/image_155071595.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Top 10 Fortune 500 industry leaders show strong yields. See why Energy Transferâs high-dividend, low-price stock stands out as a safer buy in December.",
      "url": "https://finnhub.io/api/news?id=294dcff3250f20a4f41dbf0edac6759822db14a529fa357fbddcf1120756d296"
    }
  },
  {
    "ts": null,
    "headline": "SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study",
    "summary": "Treatment with a Sanofi-Teva-partnered experimental drug meets the primary goals in a mid-stage study for Ulcerative colitis and Crohn's disease indications.",
    "url": "https://finnhub.io/api/news?id=c3dbdf52256b0c9b2a2a05ed9a878d078889a8162d22f3186a8fdd21ae230695",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734528060,
      "headline": "SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study",
      "id": 132039476,
      "image": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Treatment with a Sanofi-Teva-partnered experimental drug meets the primary goals in a mid-stage study for Ulcerative colitis and Crohn's disease indications.",
      "url": "https://finnhub.io/api/news?id=c3dbdf52256b0c9b2a2a05ed9a878d078889a8162d22f3186a8fdd21ae230695"
    }
  },
  {
    "ts": null,
    "headline": "Tessera gets sickle cell funding; Corvus shares slide on eczema data",
    "summary": "The Bill & Melinda Gates Foundation will invest up to $50 million in Tessera’s in vivo sickle cell therapy. Elsewhere, Cara agreed to a reverse merger and J&J had a drug application rejected.",
    "url": "https://finnhub.io/api/news?id=52cf94ebb37cb8d7c0bbb601f5e7ffae823ea73b57caa3ce4199c0f573e20814",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734522300,
      "headline": "Tessera gets sickle cell funding; Corvus shares slide on eczema data",
      "id": 132043976,
      "image": "https://imgproxy.divecdn.com/EK5xKj0ydykvmwFmBqsauREtdhrHAUsAiyI6JgDkO1s/g:nowe:0:0/c:1207:682/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webp",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The Bill & Melinda Gates Foundation will invest up to $50 million in Tessera’s in vivo sickle cell therapy. Elsewhere, Cara agreed to a reverse merger and J&J had a drug application rejected.",
      "url": "https://finnhub.io/api/news?id=52cf94ebb37cb8d7c0bbb601f5e7ffae823ea73b57caa3ce4199c0f573e20814"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Participates in the Inauguration of World Health Organization (WHO) Academy to Improve Training and Education of Health Workers Globally",
    "summary": "Lyon, France - Johnson & Johnson participated today along with the Government of France and health care leaders from around the world in the inauguration of the WHO Academy campus in Lyon, France.The...",
    "url": "https://finnhub.io/api/news?id=0f86190a76a95e255ff3e97edeae091ba0d6d532802b776d4e3e6347568415e4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734518295,
      "headline": "Johnson & Johnson Participates in the Inauguration of World Health Organization (WHO) Academy to Improve Training and Education of Health Workers Globally",
      "id": 132039427,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Lyon, France - Johnson & Johnson participated today along with the Government of France and health care leaders from around the world in the inauguration of the WHO Academy campus in Lyon, France.The...",
      "url": "https://finnhub.io/api/news?id=0f86190a76a95e255ff3e97edeae091ba0d6d532802b776d4e3e6347568415e4"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Participates in the Inauguration of World Health Organization Academy to Improve Training and Education of Health Workers Globally",
    "summary": "Lyon, France - Johnson & Johnson participated today along with the Government of France and health care leaders from around the world in the inauguration of the WHO Academy campus in Lyon, France.The...",
    "url": "https://finnhub.io/api/news?id=87508e7c5505493c89d7f6d155b4aa4bd425f918507a69cf0dc877093b39e810",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734518030,
      "headline": "Johnson & Johnson Participates in the Inauguration of World Health Organization Academy to Improve Training and Education of Health Workers Globally",
      "id": 132039385,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Lyon, France - Johnson & Johnson participated today along with the Government of France and health care leaders from around the world in the inauguration of the WHO Academy campus in Lyon, France.The...",
      "url": "https://finnhub.io/api/news?id=87508e7c5505493c89d7f6d155b4aa4bd425f918507a69cf0dc877093b39e810"
    }
  },
  {
    "ts": null,
    "headline": "The Smartest Dividend Stocks to Buy With $500 Right Now",
    "summary": "If you add a few dividend stocks to your portfolio, you'll start collecting returns on a regular basis -- without lifting a finger.  Loads of companies pay dividends, so it might seem difficult make a selection.  A great way to start is to consider the list of Dividend Kings, companies that have increased their dividend payments for at least 50 consecutive years.",
    "url": "https://finnhub.io/api/news?id=7322786cf271d95be7886709d83333a246569c9fc0336b59ba513b32858ae8ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734516900,
      "headline": "The Smartest Dividend Stocks to Buy With $500 Right Now",
      "id": 132041841,
      "image": "https://g.foolcdn.com/editorial/images/801154/gettyimages-135538318.jpg",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "If you add a few dividend stocks to your portfolio, you'll start collecting returns on a regular basis -- without lifting a finger.  Loads of companies pay dividends, so it might seem difficult make a selection.  A great way to start is to consider the list of Dividend Kings, companies that have increased their dividend payments for at least 50 consecutive years.",
      "url": "https://finnhub.io/api/news?id=7322786cf271d95be7886709d83333a246569c9fc0336b59ba513b32858ae8ed"
    }
  },
  {
    "ts": null,
    "headline": "J&J: applies to the EMA for an expanded indication for Imbruvica",
    "summary": "J&J announces that its subsidiary Janssen-Cilag International has applied to the European Medicines Agency to extend the indication of Imbruvica in combination with the R-CHOP protocol in the...",
    "url": "https://finnhub.io/api/news?id=27166722cb5ac3488680dc959e18a392e72619646cb0177e8c1cd4db0384829a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734516256,
      "headline": "J&J: applies to the EMA for an expanded indication for Imbruvica",
      "id": 132039231,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "J&J announces that its subsidiary Janssen-Cilag International has applied to the European Medicines Agency to extend the indication of Imbruvica in combination with the R-CHOP protocol in the...",
      "url": "https://finnhub.io/api/news?id=27166722cb5ac3488680dc959e18a392e72619646cb0177e8c1cd4db0384829a"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson : submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA® (ibrutinib) in adult patients with previously untreated mantle cell lymphoma (MCL) who are eligible for autologous stem cell transplant",
    "summary": "Johnson & Johnson submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA ® in adult patients with...",
    "url": "https://finnhub.io/api/news?id=be1635301740b9d4d3eb8801f9b4ac00e1a1f804f8d3fa22378ce7f3eeb85dd2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734510582,
      "headline": "Johnson & Johnson : submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA® (ibrutinib) in adult patients with previously untreated mantle cell lymphoma (MCL) who are eligible for autologous stem cell transplant",
      "id": 132038567,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA ® in adult patients with...",
      "url": "https://finnhub.io/api/news?id=be1635301740b9d4d3eb8801f9b4ac00e1a1f804f8d3fa22378ce7f3eeb85dd2"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys",
    "summary": "Financial writer achieves record dividend income in November through investments in BDCs, inching closer to $10,000 annual goal.",
    "url": "https://finnhub.io/api/news?id=1622bfcd6476b1f6935d84f1ad53065555594e875fe18e2d92fb59ae55233c0a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734509400,
      "headline": "My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys",
      "id": 132038523,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Financial writer achieves record dividend income in November through investments in BDCs, inching closer to $10,000 annual goal.",
      "url": "https://finnhub.io/api/news?id=1622bfcd6476b1f6935d84f1ad53065555594e875fe18e2d92fb59ae55233c0a"
    }
  }
]